Excellence in Autoantibody Research (EXAR) is an edition of the Institute of Rheumatic and Autoimmune Diseases (INRADIS)


Journal type: e-Journal, Open access
Published by: INRADIS (Institute of Rheumatic and Autoimmune Diseases)
Language: English
Contact: exarjournal@yahoo.com
Website: www.exarjournal.com

Editor-in-Chief: Professor Dimitrios P. Bogdanos
Honorary Editor in Chief: Professor Lazaros I. Sakkas

Excellence in Autoantibody Research (EXAR) is a peer reviewed, International journal dedicated to the dissemination of cutting-edge experimental, translation and clinical research in the field of Autoantibodies.

The Journal is published On line (e-Journal) and is a Platinum Open Access Journal.

All accepted papers are published free of charge and no publication or other fees directly or indirectly related to publication are requested by the participating Authors or their Institutions.

EXAR publishes original research articles, case reports, editorials, commentaries, reviews, letters and images on all aspects of the pathogenic, diagnostic and clinical significance of autoantibodies in autoimmune diseases and other inflammatory diseases.

The goal of this Journal is to keep a record of the state-of-the-art research and to promote information and knowledge about study, research, clinical practise and on-going developments within its various specialties and sub-specialties related to the field of autoimmunity, rheumatology and clinical immunology.

All manuscripts submitted to EXAR must be original, previously unpublished and may not be considered for publication elsewhere at any time during EXAR review period.

In general, accepted articles will appear online within 3-4 weeks upon acceptance. The journal publishes original papers including but not limited to the following fields:

  • Excellence on the diagnostic significance of autoantibodies in autoimmune diseases
  • Excellence on the clinical and prognostic significance of autoantibodies
  • Excellence on Clinical, experimental and translational research aspects of autoantibodies in organ-specific and non-organ specific Autoimmune diseases
  • Excellence on the role of autoantibodies in the criteria of diagnosis of autoimmune diseases
  • Excellence on environmental, genetic and epigenetic factors related to autoantibody presence in Autoimmune Diseases
  • Excellence on the pathogenic mechanisms responsible for the induction of autoantibodies
  • Excellence on methods used for the detection of autoantibodies
  • Excellence on all aspects of laboratory testing and reporting of autoantibodies in routine practice
  • Excellence of autoantibody research as biomarkers
  • Excellence on autoantibody induction after initiation of biologic drugs
  • Excellence on unmet needs in autoantibody research in Rheumatology, Autoimmunology and Clinical Immunology practice
  • Excellence on the role of autoantibodies in the diagnosis of emerging immune-mediated and cancerous diseases

The Journal accepts and publishes all types of papers, including but not limited to original research articles, case reports, editorials, commentaries, reviews, letters and images on all aspects of clinical and experimental autoimmune and rheumatic diseases.

Short papers are pee-reviewed in a fast track process and if accepted are published in press within 10 days.

Authors of selected short papers would be invited to write a regular paper on the same topic for future issues of the Journal.